Girl, 13, is first in Britain to have new cervical cancer vaccine 23rd October 2006 Vaccine: Hollie Anderson with her mum, Lisa. A thirteen-year-old London girl has become the first in the country to receive the cervical cancer vaccine. Hollie Anderson's mother, Lisa, paid £450 for her to have the jab privately after seeing her own mother battle against cancer. The vaccine, Gardasil, launched in Britain last week, protects against the main viruses that cause the cancer but the Government has not yet issued guidance on which groups will be routinely immunised. The confusion means mothers are taking their daughters to private clinics instead. Mrs Anderson, a child psychologist from Enfield, said: "Every mother and every daughter should have this vaccine. I've seen how awful the disease can be. I saw it as my role to protect Hollie." She signed up Hollie for the three injections after her mother Shirley Hart, 67, was given the all-clear by doctors following a course of radiotherapy. Mrs Anderson, 44, said: "When I found out from our doctor that these injections were becoming available it wasn't a difficult choice to make. I asked Hollie and she said she wanted it. It was her decision. Afterwards she said, 'Thank you mum, I know you're protecting me against a disease.' "She's been telling all her friends about it and trying to talk them into getting it. It's become something she's proud of, being the first girl in the country to have it." There are 2,800 new cases of cervical cancer diagnosed in Britain every year. About 1,000 women die. Hollie, who attends Immanuel College, Bushey, said: "I did research and saw how bad cervical cancer is. "When we heard [the vaccine] was coming out in England I asked mum if I could have it. I think it's better to be safe. All my friends are asking their parents if they can have it." Gardasil targets human papilloma viruses linked to cervical cancer, which are transmitted through sex. The jab is licensed for all children aged nine to 13 and women aged 16 to 26. It should be given before patients become sexually active. Dr George Kassianos, the Royal College of General Practioners' immunisation spokesman, said: "This vaccine is available on prescription today, but patients should wait for the Department of Health to give us guidance. Everyone agrees this is a great leap forward. I would ask the department to fasttrack a decision." However, Dr Sarah Lotzof, of Dedicated Doctors, in Totteridge, said: "We're booked up months ahead. We're the first practice in the country to offer the vaccinations and there is a huge demand." A spokeswoman for the Department of Health said it was not yet known when a decision will be made on which groups should routinely receive the vaccine. However, GPs will be reimbursed for the cost of any vaccines they administer to patients. The vaccine's maker, Sanofi Pasteur MSD, said last week that the cost to the NHS of three doses is £241.50, but if a mass campaign was launched there would be a discount.